Shire Ireland currently focuses on the following therapeutic areas:
Attention Deficit Hyperactivity Disorder (ADHD),
Fabry Disease, Gaucher Disease,
Hunter Syndrome, Chronic
Shire Ireland is a market leader in providing adjunctive therapies for
patients with osteoporosis
through our range of calcium-based supplements.
Shire Ireland brings the same focus and dedication to
gastrointestinal and renal
(kidney) diseases, with products for the treatment of mild to moderate
ulcerative colitis, a type of inflammatory bowel disease, and a phosphate
binder for use in some patients with chronic kidney disease.
Through the commitment of our employees, we are making a difference to
patients, their families and carers, as well as to the medical community.